Skip to content
OpenCapital
Get started

UMH Properties UMH Marketable Securities Unrealized Gain Loss

Marketable Securities Unrealized Gain Loss at other companies

Healthcare Services Group logo
Healthcare Services GroupHCSG
$475K+480%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$200K0.0%
UMH
UMH PropertiesUMH
-$36.42M—
Allison Transmission Holdings logo
Allison Transmission HoldingsALSN
$3M0.0%
Braze, Inc. logo
Braze, Inc.BRZE
-$1.3M-224%
BioLife Solutions logo
BioLife SolutionsBLFS
-$252K-2,700%

Other financials

Income statement

See full
Revenue$65.8M+7.5%
Net income$7.7M+59.9%
EPS (diluted)$0.03—

Balance sheet

See full
Cash & equivalents$37.4M+6.3%
Total debt$149.3M+13.9%
Total equity$894.4M-2.0%
Total assets$1.7B+8.9%

Cash flow

See full
Operating cash flow$20.8M+63.1%
CapEx$24.4M+18.1%
Free cash flow-$3.6M+54.9%

Valuation

See full
Market cap$1.31B-7.2%
P/E44.8×-5.7×
P/S4.9×-0.9×

Profitability

See full
Gross margin91.2%—
Net margin10.9%-0.5pp
FCF margin-10.5%—

Returns & leverage

See full
Return on equity3.2%-0.2pp
Debt / equity0.2×0.0×

Where this comes from

Reported directly by UMH Properties in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesUnrealizedGainLoss.

The official record: UMH Properties’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about UMH Properties's marketable securities unrealized gain loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is UMH Properties's marketable securities unrealized gain loss?
UMH Properties (UMH) reported marketable securities unrealized gain loss of -$36.42M in Q1 2026.
What is the long-term trend for UMH Properties's marketable securities unrealized gain loss?
Over 2 years (2022 to 2025), UMH Properties's marketable securities unrealized gain loss has grown at a -81.4% compound annual growth rate (CAGR), from $6.39M to -$221K.
What does marketable securities unrealized gain loss mean?
Represents the change in the fair market value of investment securities that have not yet been sold. This metric highlights the volatility and performance of the company's liquid investment portfolio.